1.0800
+0.0500
+(4.85%)
At close: January 29 at 5:29:43 PM GMT+1
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
14,869.0000
21,701.0000
25,810.0000
15,991.0000
Total Liabilities Net Minority Interest
3,838.0000
7,709.0000
1,893.0000
6,755.0000
Total Equity Gross Minority Interest
11,031.0000
13,992.0000
23,917.0000
9,236.0000
Total Capitalization
11,031.0000
13,992.0000
23,917.0000
9,289.0000
Common Stock Equity
11,031.0000
13,992.0000
23,917.0000
9,236.0000
Net Tangible Assets
3,582.0000
4,566.0000
11,766.0000
-2,562.0000
Working Capital
3,360.0000
4,109.0000
11,543.0000
-2,571.0000
Invested Capital
11,031.0000
13,992.0000
53.0000
11,947.0000
Tangible Book Value
3,582.0000
4,566.0000
11,766.0000
-2,562.0000
Total Debt
--
--
53.0000
2,711.0000
Net Debt
--
--
--
1,226.0000
Share Issued
18,600.4800
12,013.5040
9,629.0550
6,291.1760
Ordinary Shares Number
18,600.4800
12,013.5040
9,629.0550
6,291.1760
12/31/2020 - 12/6/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
XSPRAY.ST Xspray Pharma AB (publ)
31.50
+0.64%
XBRANE.ST Xbrane Biopharma AB (publ)
0.1836
+0.33%
ONCO.ST Oncopeptides AB (publ)
1.4080
+0.72%
IFRX InflaRx N.V.
2.2400
-0.44%
ACXP Acurx Pharmaceuticals, Inc.
0.7300
-6.05%
ALK-B.CO ALK-Abelló A/S
151.90
-3.62%
IOBT IO Biotech, Inc.
0.9400
-1.05%
CLLS Cellectis S.A.
1.5200
-1.30%
CRIS Curis, Inc.
3.2200
+2.88%
GUBRA.CO Gubra A/S
672.00
+2.13%